Federal Circuit revives Apotex blood pressure case

01-04-2015

Federal Circuit revives Apotex blood pressure case

THPStock / Shutterstock.com

A US appeals court has overturned a district court's decision to deny Apotex's request for a declaratory judgment that its proposed generic blood pressure drug would not infringe a patent owned by pharmaceutical company Daiichi Sankyo.


US Court of Appeals for the Federal Circuit, Apotex, Daiichi Sankyo, Mylan, Benicar, patent disclaimer

LSIPR